Trials / Recruiting
RecruitingNCT06513273
Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)
Observational GIMEMA Study on the Outcome of Acute Myeloid Leukemia (AML) Patients Treated With New Drugs in Real-life
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 397 (estimated)
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter, prospective and retrospective observational study aims to evaluate the use and efficacy of new drugs or their combinations in real-life in a population of adult AML patients.
Detailed description
This multicenter, prospective and retrospective observational study (model: case only) aims to evaluate the use and efficacy of new drugs or their combinations in real-life in a population of adult AML patients treated at Italian GIMEMA centers. No additional procedures or visits other than those required by normal clinical practice will be required. every patient will be followed for a minimum of 24 months.
Conditions
Timeline
- Start date
- 2025-07-11
- Primary completion
- 2029-12-01
- Completion
- 2029-12-01
- First posted
- 2024-07-22
- Last updated
- 2025-08-13
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT06513273. Inclusion in this directory is not an endorsement.